Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1980 Jun;39(3):228–230. doi: 10.1136/ard.39.3.228

Serum amyloid protein levels in south american children with rheumatoid arthritis: a co-operative study.

M A Scheinberg, O Hubscher, O G Morteo, M D Benson
PMCID: PMC1000521  PMID: 7416812

Abstract

Serum amyloid protein (SAA) levels were determined by radioimmunoassay in 90 children with juvenile rheumatoid arthritis (JRA). Significantly higher levels of SAA were present in children with the polyarticular and systemic forms of the disease. SAA levels correlate with disease activity, increasing during acute exacerbations, decreasing during remission and in patients having prednisone therapy. High serum SAA concentrations in children with JRA did not correlate with the presence of secondary amyloidosis and may be useful as a disease monitor.

Full text

PDF
228

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANSELL B. M., BYWATERS E. G. Prognosis in Still's disease. Bull Rheum Dis. 1959 May;9(9):189–192. [PubMed] [Google Scholar]
  2. Benson M. D., Scheinberg M. A., Shirahama T., Cathcart E. S., Skinner M. Kinetics of serum amyloid protein A in casein-induced murine amyloidosis. J Clin Invest. 1977 Mar;59(3):412–417. doi: 10.1172/JCI108654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Filipowicz-Sosnowska A. M., Roztropowicz-Denisiewicz K., Rosenthal C. J., Baum J. The amyloidosis of juvenile rheumatoid arthritis--comparative studies in Polish and American children. I. Levels of serum SAA protein. Arthritis Rheum. 1978 Jul-Aug;21(6):699–703. doi: 10.1002/art.1780210615. [DOI] [PubMed] [Google Scholar]
  4. García-Morteo O., Hübscher O., Gagliardi S. Amyloidosis in juvenile rheumatoid arthritis. Arthritis Rheum. 1978 Sep-Oct;21(7):867–868. doi: 10.1002/art.1780210727. [DOI] [PubMed] [Google Scholar]
  5. Hunter W. M. Radioimmunoassay and saturation analysis. Preparation and assessment of radioactive tracers. Br Med Bull. 1974 Jan;30(1):18–23. doi: 10.1093/oxfordjournals.bmb.a071161. [DOI] [PubMed] [Google Scholar]
  6. Rostropowicz-Denisiewicz, Maldyk E., Wagner T. Skrobiawica w przebiegu gosćca przewlekłego postepujacego u dzieci. Pediatr Pol. 1968 Mar;43(3):311–315. [PubMed] [Google Scholar]
  7. Scheinberg M. A., Cathcart E. S. New concepts in the pathogenesis of primary and secondary amyloid disease. Clin Exp Immunol. 1978 Jul;33(1):185–190. [PMC free article] [PubMed] [Google Scholar]
  8. Scheinberg M. A. Immunology of amyloid disease: a review. Semin Arthritis Rheum. 1977 Nov;7(2):133–140. doi: 10.1016/0049-0172(77)90019-1. [DOI] [PubMed] [Google Scholar]
  9. Smith M. E., Ansell B. M., Bywaters E. G. Mortality and prognosis related to the amyloidosis of Still's disease. Ann Rheum Dis. 1968 Mar;27(2):137–145. doi: 10.1136/ard.27.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. YALOW R. S., BERSON S. A. Immunoassay of endogenous plasma insulin in man. J Clin Invest. 1960 Jul;39:1157–1175. doi: 10.1172/JCI104130. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES